The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Clinical trial NCT02618928 · COMPLETED

Trial details

NCT number: NCT02618928
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C

Start date: 2015-12-15
Primary completion: 2018-03-29
Enrollment: 735

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.